# NIH R01 Specific Aims - Large Language Models for Biomedical Discovery

## PROBLEM STATEMENT AND SIGNIFICANCE

Large language models (LLMs) have demonstrated remarkable capabilities in natural language understanding and generation, yet their application to biomedical research is severely limited by three critical gaps:

1. **Interpretability Gap**: We lack understanding of how LLMs encode and reason about biomedical concepts, hampering their reliable use in clinical and research settings.

2. **Reliability Problem**: LLMs frequently hallucinate incorrect information—critical limitation for high-stakes medical applications where accuracy is paramount.

3. **Knowledge Integration Deficit**: LLMs struggle to integrate dynamic biomedical knowledge (proteins, drugs, genes) with textual information, limiting their utility for precision medicine.

These limitations constrain deployment of LLMs in biomedical discovery and clinical decision support despite enormous potential to accelerate research and improve outcomes.

---

## LONG-TERM GOAL AND IMMEDIATE OBJECTIVES

**Long-Term Goal**: Develop interpretable, reliable, and knowledge-integrated large language models that serve as expert tools for biomedical research and clinical decision support.

**Immediate Objectives**: This R01 will develop foundational methods for:
1. Understanding how LLMs encode and retrieve biomedical knowledge
2. Reducing hallucinations in biomedical text generation
3. Integrating structured biomedical knowledge with language models
4. Validating performance on biomedical discovery tasks

---

## CENTRAL HYPOTHESIS

We hypothesize that combining mechanistic interpretability analysis, consistency training, and structured knowledge integration will produce LLMs that:
- Reliably retrieve and apply biomedical knowledge
- Generate factually accurate biomedical text
- Outperform existing tools on biomedical discovery tasks

---

## SPECIFIC AIMS

### AIM 1: Identify and Characterize Biomedical Knowledge Circuits in LLMs

**Hypothesis**: LLMs encode biomedical knowledge in identifiable, modular circuits that can be analyzed, understood, and modified.

**Rationale**: Current interpretability research focuses on general language understanding. Biomedical knowledge has distinct characteristics (specialized terminology, structured relationships, dynamic updates) requiring specialized analysis. Understanding these circuits will reveal how models retrieve medical knowledge and where errors occur.

**Approach**:
- Implement activation patching to trace knowledge retrieval pathways for biomedical entities
- Develop circuit identification methods specific to structured knowledge (proteins, drugs, genes)
- Create visualizations of biomedical knowledge circuits
- Validate circuits through systematic ablation studies

**Expected Outcomes**:
- Characterization of knowledge circuits for top 100 biomedical concepts
- Identification of knowledge retrieval failure modes
- Publications on mechanistic understanding of biomedical LLMs

---

### AIM 2: Develop Consistency Training and Hallucination Reduction Methods for Biomedical Text

**Hypothesis**: Specialized consistency training can reduce hallucination rates in biomedical LLMs by 50%+ while maintaining task performance.

**Rationale**: General hallucination reduction methods may not adequately address biomedical errors (e.g., drug-interaction false positives are particularly dangerous). Biomedical-specific training and evaluation are needed.

**Approach**:
- Develop biomedical consistency training objectives emphasizing factual accuracy
- Implement knowledge-grounded decoding using biomedical knowledge bases
- Create uncertainty quantification calibrated for medical risk
- Evaluate on biomedical hallucination benchmarks

**Expected Outcomes**:
- Biomedical consistency training methods
- >50% reduction in hallucinations on medical NLI and fact verification tasks
- Uncertainty quantification validated on clinical decision scenarios

---

### AIM 3: Create Knowledge-Integrated Language Models for Biomedical Entity Reasoning

**Hypothesis**: Integrating structured biomedical knowledge (proteins, genes, drugs) with language models produces superior performance on biomedical discovery tasks compared to language-only models.

**Rationale**: Biomedical entities have structured properties (molecular weight, binding sites, interactions) that pure language models struggle to incorporate. Knowledge graphs and structured databases provide complementary information that language models can leverage.

**Approach**:
- Implement retrieval-augmented generation with biomedical knowledge bases
- Develop entity-aware architectures with specialized reasoning modules
- Create methods for reasoning over biomedical knowledge graphs
- Integrate drug interactions, protein interactions, and gene-phenotype associations

**Expected Outcomes**:
- Knowledge-integrated LLM architecture
- Superior performance on entity-centric biomedical tasks
- Evaluation on drug discovery, protein function prediction, disease-gene association

---

### AIM 4: Validate Performance on Biomedical Discovery and Clinical Decision Support Tasks

**Hypothesis**: LLMs developed with interpretability, consistency, and knowledge integration will substantially outperform existing tools on biomedical discovery tasks and provide reliable clinical decision support.

**Rationale**: Validation on realistic biomedical tasks is essential to demonstrate clinical relevance and guide further development. Focus on tasks with clear ground truth (drug discovery benchmarks) and tasks directly relevant to clinical care (clinical decision support).

**Approach**:
- Evaluate on standard biomedical NLP benchmarks (BioASQ, PubMedQA, MedQA)
- Create novel benchmarks for knowledge-dependent discovery tasks
- Implement clinical decision support prototype on real clinical questions
- Compare to domain-specific tools (drug discovery software, clinical decision support systems)
- Measure accuracy, latency, and reliability metrics

**Expected Outcomes**:
- Benchmark performance on 10+ biomedical discovery tasks
- Clinical decision support prototype with human evaluation
- Publications in biomedical informatics venues
- Released models for biomedical community

---

## PAYOFF AND SIGNIFICANCE

Success in these aims will:

1. **Advance Scientific Knowledge**: Enable computational identification of new drug-disease associations, protein functions, and therapeutic targets

2. **Improve Clinical Practice**: Provide clinicians with reliable AI-assisted decision support integrated with medical literature

3. **Accelerate Biomedical Research**: Enable researchers to synthesize complex biomedical literature and identify novel hypotheses

4. **Establish Best Practices**: Create gold-standard methods for reliable, interpretable biomedical AI that will be adopted broadly

5. **Train Workforce**: Produce PhD graduates and postdocs with expertise in interpretable, reliable AI for medicine

6. **Generate Resources**: Release open-source models, benchmarks, and tools for biomedical community

**Impact**: This work will establish principled approaches to deploying LLMs in biomedicine, with direct applications to drug discovery, precision medicine, and clinical decision support. Expected outcomes will influence development of reliable AI systems across biomedical research and clinical practice.
